It could be argued however that because CD59 is acting on inhibition of the MAC formation which is more directly and immediately responsible for tumor killing, the blockade of CD59 in conjunction with immunocheckpoint inhibitor therapy may be useful. The gene discussed is CD59; the disease is neoplasm.